Disparities in Age-Specific Morbidity and Mortality from SARS-CoV-2 in China and the Republic of Korea

Viral Infections, Non-HIV

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

N Engl J Med.

van Doremalen N, Bushmaker T, Morris DH, Holbrook MG, Gamble A, Williamson BN, Tamin A, Harcourt JL, Thornburg NJ, Gerber SI, Lloyd-Smith JO, de Wit E, Munster VJ

doi: 10.1056/NEJMc2004973.

Viral Infections, Non-HIV

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Viruses.

Ahmed SF, Quadeer AA, McKay MR

doi: 10.3390/v12030254.

Viral Infections, Non-HIV

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Lancet Infect Dis

Zhang Y, Zeng G, Pan H, Li C, Hu Y, Chu K, Han W, Chen Z, Tang R, Yin W, Chen X, Hu Y, Liu X, Jiang C, Li J, Yang M, Song Y, Wang X, Gao Q, Zhu F

doi: 10.1016/S1473-3099(20)30843-4

Viral Infections, Non-HIV

Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients

Aliment Pharmacol Ther.

Romana Ponziani F, Del Zompo F, Nesci A, Santopaolo F, Ianiro G, Pompili M, Gasbarrini A, “Gemelli against COVID-19” group.

doi: 10.1111/apt.15996.

Viral Infections, Non-HIV

Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019

Clin Infect Dis.

Magleby R, Westblade LF, Trzebucki A, Simon MS, Rajan M, Park J, Goyal P, Safford MM, Satlin MJ

doi: 10.1093/cid/ciaa851.

Viral Infections, Non-HIV

Antibody tests for identification of current and past infection with SARS-CoV-2

Cochrane Database Syst Rev.

Deeks JJ, Dinnes J, Takwoingi Y, Davenport C, Spijker R, Taylor-Phillips S, Adriano A, Beese S, Dretzke J, Ferrante di Ruffano L, Harris IM, Price MJ, Dittrich S, Emperador D, Hooft L, Leeflang MM, Van den Bruel A, Cochrane COVID-19 Diagnostic Test Accuracy Group.

doi: 10.1002/14651858.CD013652.

Viral Infections, Non-HIV

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Lancet Infect Dis

Wu Z, Hu Y, Xu M, Chen Z, Yang W, Jiang Z, Li M, Jin H, Cui G, Chen P, Wang L, Zhao G, Ding Y, Zhao Y, Yin W

doi: 10.1016/S1473-3099(20)30987-7

Viral Infections, Non-HIV

Coinfection with HIV and SARS-CoV-2 in Wuhan, China: A 12-person case series

J Acquir Immune Defic Syndr.

Hu Y, Ma J, Huang H, Vermund SH

doi: 10.1097/QAI.0000000000002424.

Viral Infections, Non-HIV

Age-Related differences in immunological responses to SARS-CoV-2

J Allergy Clin Immunol Pract

Yin Wong LS, Ling Loo EX, Hui Kang AY, Lau HX, Tambyah PA, Tham EH

doi: 10.1016/j.jaip.2020.08.026

Related content

Aerosol and Surface Stability of SARS-CoV-2 as Compared with SARS-CoV-1

Preliminary Identification of Potential Vaccine Targets for the COVID-19 Coronavirus (SARS-CoV-2) Based on SARS-CoV Immunological Studies

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine in healthy adults aged 18-59 years: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Liver involvement is not associated with mortality: results from a large cohort of SARS-CoV-2 positive patients

Impact of SARS-CoV-2 Viral Load on Risk of Intubation and Mortality Among Hospitalized Patients with Coronavirus Disease 2019

Antibody tests for identification of current and past infection with SARS-CoV-2

Safety, tolerability, and immunogenicity of an inactivated SARS-CoV-2 vaccine (CoronaVac) in healthy adults aged 60 years and older: a randomised, double-blind, placebo-controlled, phase 1/2 clinical trial

Coinfection with HIV and SARS-CoV-2 in Wuhan, China: A 12-person case series

Age-Related differences in immunological responses to SARS-CoV-2